For 25 years, Steven Halpern, editor of TheStockAdvisors.com, has surveyed the leading financial newsletter advisors asking for their favorite stocks for the coming year. This article is one of 100+ ideas in the Best Stocks for 2008 report.
"Nanotech has an incredibly broad application spectrum and the sector offers enormous opportunities," explains Gregg Early in The Real Nanotech Investor.
"My conservative favorite for 2008 is Bayer (OTC: BAYRY). Although the stock is up 50% since we first added it to our portfolio less than a year ago, its return isn't surprising given current market conditions.
"Bayer has a number of things going for it beyond its significant incorporation of nanotech into various product lines; it even sells Baytubes, proprietary ready-to-use, multi-walled carbon nanotubes. It's also a big, safe stock.
"But it's still undervalued relative to its pharma competitors. And it's a German company that has the spending power of a euro-based firm with significant exposure in every major developed and developing market in the world.
"That's why the rumors continue regarding Bayer becoming a great acquisition for one of its deep-pocketed competitors.
"That's also why I expect another huge year for the company. But we may have to satisfy ourselves with lesser double-digit gains year in and year out, for years to come. Either way, this is a solid growth stock with an innovation streak and a wide, short pipeline from 'lab to fab.'
"The stock trades over the counter as a top tier Y share. Bayer delisted from the NYSE earlier this year because it didn't want to deal with dual filing standards in the US and European Union."